A pathology-based substrate for target definition in radiosurgery of brain metastases

Brigitta G Baumert1, Isabelle Rutten, Cary Dehing-Oberije

  • 1Department of Radiation Oncology (MAASTRO), GROW, University Hospital Maastricht, Maastricht, The Netherlands. brigitta.baumert@maastro.nl

Abstract

Insights

Histopathology revealed infiltrative growth in 63% of brain metastases, necessitating a margin beyond visible borders for stereotactic radiosurgery (SRS). A 1 mm margin is recommended for accurate treatment planning in brain metastases SRS.

Area of Science:

  • Neurology
  • Oncology
  • Pathology

Background:

  • Brain metastases pose significant challenges in stereotactic radiosurgery (SRS).
  • Accurate delineation of tumor boundaries is crucial for effective SRS planning.
  • The extent of microscopic infiltration beyond visible tumor margins remains an area of investigation.

Purpose of the Study:

  • To histopathologically investigate the necessity of a margin beyond accuracy considerations in stereotactic radiosurgery for brain metastases.
  • To determine the extent of infiltrative growth in brain metastases.

Main Methods:

  • Evaluation of 45 patient autopsy brain samples with metastases.
  • Immunohistochemical staining to visualize tumor, glial, and soft tissue markers.
  • Analysis of infiltration depth and number of sites, with correction for tissue shrinkage.

Main Results:

  • Infiltration beyond metastasis boundaries was observed in 63% of cases (48/76 metastases).
  • Small-cell lung cancer (SCLC) and melanoma showed infiltration depths of >= 1 mm.
  • Non-small-cell lung cancer (NSCLC) exhibited the highest infiltration percentage (70%).

Conclusions:

  • Microscopic infiltrative growth beyond visible brain metastases is common.
  • This infiltrative growth impacts the definition of the clinical target volume for SRS.
  • A margin of approximately 1 mm should be added to the visible lesion for SRS planning.